Danisco
Danish food ingredients company
Danisco A/S was a Danish food ingredients company that specialized in the production of enzymes, biotechnology, and other food-related products. Founded in 1989, Danisco quickly became a significant player in the global food industry, providing essential ingredients for a wide range of food products.
History[edit | edit source]
Danisco was established in 1989 through the merger of Danish Sugar (Dansk Sukker) and Finnish company Cultor. The company expanded its operations by acquiring several other businesses in the food ingredients sector, including the British company, Genencor, which specialized in enzymes and biotechnology.
In 2011, Danisco was acquired by the American conglomerate DuPont, which integrated Danisco's operations into its own DuPont Nutrition & Biosciences division. This acquisition allowed DuPont to enhance its capabilities in the food ingredients and biotechnology sectors.
Products and Services[edit | edit source]
Danisco's product portfolio included a wide range of food ingredients and solutions, such as:
- Enzymes: Used in various food processing applications to improve texture, flavor, and shelf life.
- Cultures: Microbial cultures for dairy products, meat, and other fermented foods.
- Emulsifiers: Ingredients that help blend and stabilize mixtures of oil and water.
- Sweeteners: Both natural and artificial sweeteners for various food and beverage applications.
- Texturants: Ingredients that modify the texture and mouthfeel of food products.
Research and Development[edit | edit source]
Danisco was known for its strong focus on research and development (R&D). The company invested heavily in developing innovative solutions to meet the evolving needs of the food industry. Danisco's R&D efforts were aimed at improving food quality, safety, and sustainability.
Acquisition by DuPont[edit | edit source]
In January 2011, DuPont announced its intention to acquire Danisco for $6.3 billion. The acquisition was completed in May 2011, and Danisco's operations were integrated into DuPont's Nutrition & Biosciences division. This acquisition allowed DuPont to expand its presence in the food ingredients market and leverage Danisco's expertise in enzymes and biotechnology.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD